483
Abbott LaboratoriesFDA 483 - Abbott Laboratories - September 24, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Abbott Nutrition's infant formula manufacturing facility in Sturgis, MI, revealed significant deficiencies. Observations included unsanitary building conditions with standing water and contaminated equipment, inadequate equipment installation and calibration, and poor personnel hygiene practices. Additionally, the firm failed to properly monitor and document critical processing parameters for thermal processing equipment.
Open in Dashboard
ID · c5c430c3-e00d-46ae-97a4-7681512cbf2d